MyHealth@Eu Hospital Discharge Report
0.0.1 - qa-preview
150
MyHealth@Eu Hospital Discharge Report
0.0.1 - qa-preview
150
MyHealth@Eu Hospital Discharge Report - Local Development build (v0.0.1) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Official URL: http://terminology.ehdsi.eu/ValueSet/eHDSIOncologyDisease | Version: 0.0.1 | |||
| Standards status: Draft | Maturity Level: 1 | Computable Name: EHDSIOncologyDisease | ||
| Other Identifiers: OID:1.3.6.1.4.1.12559.11.10.1.3.1.42.93 | ||||
The Value Set is used for coding the site (topography) and the histology (morphology) of neoplasms
References
http://terminology.hl7.org/CodeSystem/icd-o-3| Code | Display |
| 8000/0 | Neoplasm, benign |
| 8000/1 | Neoplasm, uncertain whether benign or malignant |
| 8000/3 | Neoplasm, malignant |
| 8000/6 | Neoplasm, metastatic |
| 8000/9 | Neoplasm, malignant, uncertain whether primary or metastatic |
| 8001/0 | Tumour cells, benign |
| 8001/1 | Tumour cells, uncertain whether benign or malignant |
| 8001/3 | Tumour cells, malignant |
| 8002/3 | Malignant tumour, small cell type |
| 8003/3 | Malignant tumour, giant cell type |
| 8004/3 | Malignant tumour, spindle cell type |
| 8005/0 | Clear cell tumour, NOS |
| 8005/3 | Malignant tumour, clear cell type |
| 8010/0 | Epithelial tumour, benign |
| 8010/2 | Carcinoma in situ, NOS |
| 8010/3 | Carcinoma, NOS |
| 8010/6 | Carcinoma, metastatic, NOS |
| 8010/9 | Carcinomatosis |
| 8011/0 | Epithelioma, benign |
| 8011/3 | Epithelioma, malignant |
| 8012/3 | Large cell carcinoma, NOS |
| 8013/3 | Large cell neuroendocrine carcinoma |
| 8014/3 | Large cell carcinoma with rhabdoid phenotype |
| 8015/3 | Glassy cell carcinoma |
| 8020/3 | Carcinoma, undifferentiated, NOS |
| 8021/3 | Carcinoma, anaplastic, NOS |
| 8022/3 | Pleomorphic carcinoma |
| 8023/3 | Nuclear protein in testis (NUT) associated carcinoma |
| 8030/3 | Giant cell and spindle cell carcinoma |
| 8031/3 | Giant cell carcinoma |
| 8032/3 | Spindle cell carcinoma, NOS |
| 8033/3 | Pseudosarcomatous carcinoma |
| 8034/3 | Polygonal cell carcinoma |
| 8035/3 | Carcinoma with osteoclast-like giant cells |
| 8040/0 | Tumourlet, benign |
| 8040/1 | Tumourlet, NOS |
| 8041/3 | Small cell carcinoma, NOS |
| 8042/3 | Oat cell carcinoma |
| 8043/3 | Small cell carcinoma, fusiform cell |
| 8044/3 | Small cell carcinoma, intermediate cell |
| 8045/3 | Combined small cell carcinoma |
| 8046/3 | Non-small cell carcinoma |
| 8050/0 | Papilloma, NOS |
| 8050/2 | Papillary carcinoma in situ |
| 8050/3 | Papillary carcinoma, NOS |
| 8051/0 | Verrucous papilloma |
| 8051/3 | Verrucous carcinoma, NOS |
| 8052/0 | Squamous cell papilloma, NOS |
| 8052/2 | Papillary squamous cell carcinoma, non-invasive |
| 8052/3 | Papillary squamous cell carcinoma |
| 8053/0 | Squamous cell papilloma, inverted |
| 8054/0 | Warty dyskeratoma |
| 8054/3 | Warty carcinoma |
| 8060/0 | Squamous papillomatosis |
| 8070/0 | Actinic keratosis |
| 8070/2 | Squamous cell carcinoma in situ, NOS |
| 8070/3 | Squamous cell carcinoma, NOS |
| 8070/6 | Squamous cell carcinoma, metastatic, NOS |
| 8071/2 | Differentiated intraepithelial neoplasia |
| 8071/3 | Squamous cell carcinoma, keratinizing, NOS |
| 8072/0 | Large cell acanthoma |
| 8072/3 | Squamous cell carcinoma, large cell, nonkeratinizing, NOS |
| 8073/3 | Squamous cell carcinoma, small cell, nonkeratinizing |
| 8074/3 | Squamous cell carcinoma, spindle cell |
| 8075/3 | Squamous cell carcinoma, adenoid |
| 8076/2 | Squamous cell carcinoma in situ with questionable stromal invasion |
| 8076/3 | Squamous cell carcinoma, microinvasive |
| 8077/0 | Squamous intraepithelial neoplasia, low grade |
| 8077/2 | Squamous intraepithelial neoplasia, high grade |
| 8078/3 | Squamous cell carcinoma with horn formation |
| 8080/2 | Queyrat erythroplasia |
| 8081/2 | Bowen disease |
| 8082/3 | Lymphoepithelial carcinoma |
| 8083/3 | Basaloid squamous cell carcinoma |
| 8084/0 | Clear cell acanthoma |
| 8084/3 | Squamous cell carcinoma, clear cell type |
| 8085/3 | Squamous cell carcinoma, HPV-positive |
| 8086/3 | Squamous cell carcinoma, HPV-negative |
| 8090/1 | Basal cell tumour |
| 8090/3 | Basal cell carcinoma, NOS |
| 8091/3 | Superficial basal cell carcinoma |
| 8092/3 | Infiltrating basal cell carcinoma, NOS |
| 8093/3 | Basal cell carcinoma, fibroepithelial |
| 8094/3 | Basosquamous carcinoma |
| 8095/3 | Metatypical carcinoma |
| 8096/0 | Intraepidermal epithelioma of Jadassohn |
| 8097/3 | Basal cell carcinoma, nodular |
| 8098/3 | Adenoid basal carcinoma |
| 8100/0 | Trichoepithelioma |
| 8100/3 | Trichoblastic carcinoma |
| 8101/0 | Trichofolliculoma |
| 8102/0 | Trichilemmoma |
| 8102/3 | Trichilemmocarcinoma |
| 8103/0 | Pilar tumour |
| 8103/1 | Proliferating trichilemmal cyst |
| 8104/0 | Pilar sheath acanthoma |
| 8110/0 | Pilomatricoma, NOS |
| 8110/3 | Pilomatrical carcinoma |
| 8120/0 | Urothelial papilloma, NOS |
| 8120/2 | Urothelial carcinoma in situ |
| 8120/3 | Transitional cell carcinoma, NOS |
| 8121/0 | Sinonasal papilloma, exophytic |
| 8121/1 | Sinonasal papilloma, inverted |
| 8121/3 | Schneiderian carcinoma |
| 8122/3 | Urothelial carcinoma, sarcomatoid |
| 8123/3 | Basaloid carcinoma |
| 8124/3 | Cloacogenic carcinoma |
| 8130/1 | Papillary urothelial neoplasm of low malignant potential |
| 8130/2 | Papillary urothelial carcinoma, non-invasive |
| 8130/3 | Papillary urothelial carcinoma |
| 8131/3 | Urothelial carcinoma, micropapillary |
| 8140/0 | Adenoma, NOS |
| 8140/1 | Atypical adenoma |
| 8140/2 | Adenocarcinoma in situ, NOS |
| 8140/3 | Adenocarcinoma, NOS |
| 8140/6 | Adenocarcinoma, metastatic, NOS |
| 8141/3 | Scirrhous adenocarcinoma |
| 8142/3 | Linitis plastica |
| 8143/3 | Superficial spreading adenocarcinoma |
| 8144/0 | Adenoma, intestinal type |
| 8144/3 | Adenocarcinoma, intestinal type |
| 8145/3 | Carcinoma, diffuse type |
| 8146/0 | Monomorphic adenoma |
| 8147/0 | Basal cell adenoma |
| 8147/3 | Basal cell adenocarcinoma |
| 8148/0 | Glandular intraepithelial neoplasia, low grade |
| 8148/2 | Glandular intraepithelial neoplasia, high grade |
| 8149/0 | Canalicular adenoma |
| 8150/0 | Pancreatic neuroendocrine microadenoma |
| 8150/3 | Pancreatic neuroendocrine tumour, nonfunctioning |
| 8151/3 | Insulinoma, NOS |
| 8152/3 | Glucagonoma |
| 8153/3 | Gastrinoma |
| 8154/3 | Mixed neuroendocrine non-neuroendocrine neoplasm (MiNEN) |
| 8155/3 | Vipoma |
| 8156/3 | Somatostatinoma |
| 8158/3 | ACTH-producing tumour |
| 8160/0 | Bile duct adenoma |
| 8160/3 | Cholangiocarcinoma |
| 8161/0 | Bile duct cystadenoma |
| 8161/3 | Bile duct cystadenocarcinoma |
| 8162/3 | Perihilar cholangiocarcinoma |
| 8163/0 | Pancreatobiliary neoplasm, non-invasive |
| 8163/2 | Papillary neoplasm, pancreatobiliary-type, with high grade intraepithelial neoplasia |
| 8163/3 | Pancreatobiliary-type carcinoma |
| 8170/0 | Liver cell adenoma |
| 8170/3 | Hepatocellular carcinoma, NOS |
| 8171/3 | Hepatocellular carcinoma, fibrolamellar |
| 8172/3 | Hepatocellular carcinoma, scirrhous |
| 8173/3 | Hepatocellular carcinoma, spindle cell variant |
| 8174/3 | Hepatocellular carcinoma, clear cell type |
| 8175/3 | Hepatocellular carcinoma, pleomorphic type |
| 8180/3 | Combined hepatocellular carcinoma and cholangiocarcinoma |
| 8190/0 | Trabecular adenoma |
| 8190/3 | Trabecular adenocarcinoma |
| 8191/0 | Embryonal adenoma |
| 8200/0 | Eccrine dermal cylindroma |
| 8200/3 | Adenoid cystic carcinoma |
| 8201/2 | Cribriform carcinoma in situ |
| 8201/3 | Cribriform carcinoma, NOS |
| 8202/0 | Microcystic adenoma |
| 8204/0 | Lactating adenoma |
| 8210/0 | Adenomatous polyp, NOS |
| 8210/2 | Adenocarcinoma in situ in adenomatous polyp |
| 8210/3 | Adenocarcinoma in adenomatous polyp |
| 8211/0 | Tubular adenoma, NOS |
| 8211/3 | Tubular adenocarcinoma |
| 8212/0 | Flat adenoma |
| 8213/0 | Serrated adenoma |
| 8213/3 | Serrated adenocarcinoma |
| 8214/3 | Parietal cell carcinoma |
| 8215/3 | Adenocarcinoma of anal glands |
| 8220/0 | Adenomatous polyposis coli |
| 8220/3 | Adenocarcinoma in adenomatous polyposis coli |
| 8221/0 | Multiple adenomatous polyps |
| 8221/3 | Adenocarcinoma in multiple adenomatous polyps |
| 8230/2 | Ductal carcinoma in situ, solid type |
| 8230/3 | Solid carcinoma, NOS |
| 8231/3 | Carcinoma simplex |
| 8240/3 | Neuroendocrine tumour, NOS |
| 8241/3 | Enterochromaffin cell carcinoid |
| 8242/3 | Enterochromaffin-like cell tumour |
| 8243/3 | Goblet cell carcinoid |
| 8244/3 | Mixed adenoneuroendocrine carcinoma |
| 8245/1 | Tubular carcinoid |
| 8245/3 | Adenocarcinoid tumour |
| 8246/3 | Neuroendocrine carcinoma, NOS |
| 8247/3 | Merkel cell carcinoma |
| 8248/1 | Apudoma |
| 8249/3 | Neuroendocrine tumour, grade 2 |
| 8250/0 | Atypical adenomatous hyperplasia |
| 8250/1 | Pulmonary adenomatosis |
| 8250/2 | Adenocarcinoma in situ of lung, non-mucinous |
| 8250/3 | Lepidic adenocarcinoma |
| 8251/0 | Alveolar adenoma |
| 8251/3 | Alveolar adenocarcinoma |
| 8252/3 | Bronchiolo-alveolar carcinoma, non-mucinous |
| 8253/2 | Adenocarcinoma in situ of lung, mucinous |
| 8253/3 | Adenocarcinoma of lung, mucinous |
| 8254/3 | Adenocarcinoma of lung, mixed mucinous and non-mucinous |
| 8255/3 | Adenocarcinoma with mixed subtypes |
| 8256/3 | Minimally invasive adenocarcinoma, Non-mucinous |
| 8257/3 | Minimally invasive adenocarcinoma, Mucinous |
| 8260/0 | Papillary adenoma, NOS |
| 8260/1 | Aggressive papillary tumour |
| 8260/3 | Papillary adenocarcinoma, NOS |
| 8261/0 | Villous adenoma, NOS |
| 8261/2 | Adenocarcinoma in situ in villous adenoma |
| 8261/3 | Adenocarcinoma in villous adenoma |
| 8262/3 | Villous adenocarcinoma |
| 8263/0 | Tubulovillous adenoma, NOS |
| 8263/2 | Adenocarcinoma in situ in tubulovillous adenoma |
| 8263/3 | Adenocarcinoma in tubulovillous adenoma |
| 8264/0 | Papillomatosis, glandular |
| 8265/3 | Micropapillary carcinoma, NOS |
| 8270/0 | Chromophobe adenoma |
| 8270/3 | Chromophobe carcinoma |
| 8271/0 | Lactotroph adenoma |
| 8272/0 | Pituitary adenoma, NOS |
| 8272/3 | Pituitary carcinoma, NOS |
| 8273/3 | Pituitary blastoma |
| 8280/0 | Acidophil adenoma |
| 8280/3 | Acidophil carcinoma |
| 8281/0 | Mixed acidophil-basophil adenoma |
| 8281/3 | Mixed acidophil-basophil carcinoma |
| 8290/0 | Oxyphilic adenoma |
| 8290/3 | Oxyphilic adenocarcinoma |
| 8300/0 | Basophil adenoma |
| 8300/3 | Basophil carcinoma |
| 8310/0 | Clear cell adenoma |
| 8310/3 | Clear cell adenocarcinoma, NOS |
| 8311/1 | Hypernephroid tumour |
| 8311/3 | Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome-associated renal cell carcinoma |
| 8312/3 | Renal cell carcinoma, NOS |
| 8313/0 | Clear cell adenofibroma |
| 8313/1 | Clear cell borderline tumour |
| 8313/3 | Clear cell adenocarcinofibroma |
| 8314/3 | Lipid-rich carcinoma |
| 8315/3 | Glycogen-rich carcinoma |
| 8316/1 | Multilocular cystic renal neoplasm of low malignant potential |
| 8316/3 | Cyst-associated renal cell carcinoma |
| 8317/3 | Renal cell carcinoma, chromophobe type |
| 8318/3 | Renal cell carcinoma, sarcomatoid |
| 8319/3 | Collecting duct carcinoma |
| 8320/3 | Granular cell carcinoma |
| 8321/0 | Chief cell adenoma |
| 8322/0 | Water-clear cell adenoma |
| 8322/3 | Water-clear cell adenocarcinoma |
| 8323/0 | Mixed cell adenoma |
| 8323/1 | Clear cell papillary renal cell carcinoma |
| 8323/3 | Mixed cell adenocarcinoma |
| 8324/0 | Lipoadenoma |
| 8325/0 | Metanephric adenoma |
| 8330/0 | Follicular adenoma |
| 8330/1 | Atypical follicular adenoma |
| 8330/3 | Follicular carcinoma, NOS |
| 8331/3 | Follicular adenocarcinoma, well differentiated |
| 8332/3 | Follicular adenocarcinoma, trabecular |
| 8333/0 | Microfollicular adenoma, NOS |
| 8333/3 | Fetal adenocarcinoma |
| 8334/0 | Macrofollicular adenoma |
| 8335/1 | Follicular tumour of uncertain malignant potential |
| 8335/3 | Follicular carcinoma, minimally invasive |
| 8336/1 | Hyalinizing trabecular tumour |
| 8337/3 | Poorly differentiated thyroid carcinoma |
| 8339/3 | Follicular carcinoma, encapsulated, angioinvasive |
| 8340/3 | Papillary carcinoma, follicular variant |
| 8341/3 | Papillary microcarcinoma |
| 8342/3 | Papillary carcinoma, oncocytic variant |
| 8343/3 | Papillary carcinoma, encapsulated, of thyroid |
| 8344/3 | Papillary carcinoma, columnar cell |
| 8345/3 | Medullary thyroid carcinoma |
| 8346/3 | Mixed medullary-follicular carcinoma |
| 8347/3 | Mixed medullary-papillary carcinoma |
| 8348/1 | Well differentiated tumour of uncertain malignant potential |
| 8349/1 | Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) |
| 8350/3 | Nonencapsulated sclerosing carcinoma |
| 8360/1 | Multiple endocrine adenomas |
| 8361/0 | Juxtaglomerular tumour |
| 8370/0 | Adrenal cortical adenoma, NOS |
| 8370/3 | Adrenal cortical carcinoma |
| 8371/0 | Adrenal cortical adenoma, compact cell |
| 8372/0 | Adrenal cortical adenoma, pigmented |
| 8373/0 | Adrenal cortical adenoma, clear cell |
| 8374/0 | Adrenal cortical adenoma, glomerulosa cell |
| 8375/0 | Adrenal cortical adenoma, mixed cell |
| 8380/0 | Endometrioid adenoma, NOS |
| 8380/1 | Endometrioid adenoma, borderline malignancy |
| 8380/2 | Endometrioid intraepithelial neoplasia |
| 8380/3 | Endometrioid adenocarcinoma, NOS |
| 8381/0 | Endometrioid adenofibroma, NOS |
| 8381/1 | Endometrioid adenofibroma, borderline malignancy |
| 8381/3 | Endometrioid adenofibroma, malignant |
| 8382/3 | Endometrioid adenocarcinoma, secretory variant |
| 8383/3 | Endometrioid adenocarcinoma, ciliated cell variant |
| 8384/3 | Adenocarcinoma, endocervical type |
| 8390/0 | Skin appendage adenoma |
| 8390/3 | Adnexal adenocarcinoma, NOS |
| 8391/0 | Follicular fibroma |
| 8392/0 | Syringofibroadenoma |
| 8400/0 | Sweat gland adenoma |
| 8400/1 | Sweat gland tumour, NOS |
| 8400/3 | Sweat gland adenocarcinoma |
| 8401/0 | Apocrine adenoma |
| 8401/3 | Apocrine adenocarcinoma |
| 8402/0 | Hidradenoma, NOS |
| 8402/3 | Hidradenocarcinoma |
| 8403/0 | Spiradenoma, NOS |
| 8403/3 | Malignant eccrine spiradenoma |
| 8404/0 | Hidrocystoma |
| 8405/0 | Papillary hidradenoma |
| 8406/0 | Syringocystadenoma papilliferum |
| 8406/3 | Syringocystadenocarcinoma papilliferum |
| 8407/0 | Syringoma, NOS |
| 8407/3 | Microcystic adnexal carcinoma |
| 8408/0 | Eccrine papillary adenoma |
| 8409/0 | Poroma, NOS |
| 8409/2 | Porocarcinoma in situ |
| 8409/3 | Porocarcinoma, NOS |
| 8410/0 | Sebaceoma |
| 8410/3 | Sebaceous carcinoma |
| 8413/3 | Eccrine adenocarcinoma |
| 8420/0 | Ceruminous adenoma |
| 8420/3 | Ceruminous adenocarcinoma |
| 8430/1 | Mucoepidermoid tumour |
| 8430/3 | Mucoepidermoid carcinoma |
| 8440/0 | Cystadenoma, NOS |
| 8440/3 | Cystadenocarcinoma, NOS |
| 8441/0 | Serous cystadenoma, NOS |
| 8441/2 | Serous intraepithelial carcinoma |
| 8441/3 | Serous carcinoma, NOS |
| 8443/0 | Clear cell cystadenoma |
| 8450/0 | Papillary cystadenoma, NOS |
| 8450/3 | Papillary cystadenocarcinoma, NOS |
| 8451/1 | Papillary cystadenoma, borderline malignancy |
| 8452/1 | Solid pseudopapillary tumour of ovary |
| 8452/3 | Solid pseudopapillary neoplasm of pancreas |
| 8453/0 | Intraductal papillary-mucinous adenoma |
| 8453/2 | Intraductal papillary mucinous neoplasm with high grade dysplasia |
| 8453/3 | Intraductal papillary mucinous neoplasm with an associated invasive carcinoma |
| 8454/0 | Cystic tumour of atrio-ventricular node |
| 8460/2 | Serous borderline tumour, micropapillary variant |
| 8460/3 | Low grade serous carcinoma |
| 8461/0 | Serous surface papilloma |
| 8461/3 | High grade serous carcinoma |
| 8470/0 | Mucinous cystadenoma, NOS |
| 8470/2 | Mucinous cystic neoplasm with high-grade dysplasia |
| 8470/3 | Mucinous cystadenocarcinoma, NOS |
| 8472/1 | Mucinous cystic tumour of borderline malignancy |
| 8474/0 | Seromucinous cystadenoma |
| 8474/1 | Seromucinous borderline tumour |
| 8474/3 | Seromucinous carcinoma |
| 8480/0 | Mucinous adenoma |
| 8480/1 | Low grade appendiceal mucinous neoplasm |
| 8480/3 | Mucinous adenocarcinoma |
| 8480/6 | Pseudomyxoma peritonei |
| 8481/3 | Mucin-producing adenocarcinoma |
| 8482/3 | Mucinous carcinoma, gastric type |
| 8490/3 | Signet ring cell carcinoma |
| 8490/6 | Metastatic signet ring cell carcinoma |
| 8500/2 | Intraductal carcinoma, noninfiltrating, NOS |
| 8500/3 | Infiltrating duct carcinoma, NOS |
| 8501/2 | Comedocarcinoma, noninfiltrating |
| 8501/3 | Comedocarcinoma, NOS |
| 8502/3 | Secretory carcinoma |
| 8503/0 | Intraductal papilloma |
| 8503/2 | Noninfiltrating intraductal papillary adenocarcinoma |
| 8503/3 | Intraductal papillary adenocarcinoma with invasion |
| 8504/0 | Intracystic papillary adenoma |
| 8504/2 | Noninfiltrating intracystic carcinoma |
| 8504/3 | Encapsulated papillary carcinoma with invasion |
| 8505/0 | Intraductal papillomatosis, NOS |
| 8506/0 | Adenoma of nipple |
| 8507/2 | Intraductal micropapillary carcinoma |
| 8507/3 | Invasive micropapillary carcinoma of breast |
| 8508/3 | Cystic hypersecretory carcinoma |
| 8509/2 | Solid papillary carcinoma in situ |
| 8509/3 | Solid papillary carcinoma with invasion |
| 8510/3 | Medullary carcinoma, NOS |
| 8512/3 | Medullary carcinoma with lymphoid stroma |
| 8513/3 | Atypical medullary carcinoma |
| 8514/3 | Duct carcinoma, desmoplastic type |
| 8519/2 | Lobular carcinoma in situ, pleomorphic |
| 8520/2 | Lobular carcinoma in situ, NOS |
| 8520/3 | Lobular carcinoma, NOS |
| 8521/3 | Infiltrating ductular carcinoma |
| 8522/2 | Intraductal carcinoma and lobular carcinoma in situ |
| 8522/3 | Infiltrating duct and lobular carcinoma |
| 8523/3 | Infiltrating duct mixed with other types of carcinoma |
| 8524/3 | Infiltrating lobular mixed with other types of carcinoma |
| 8525/3 | Polymorphous adenocarcinoma |
| 8530/3 | Inflammatory carcinoma |
| 8540/3 | Paget disease, mammary |
| 8541/3 | Paget disease and infiltrating duct carcinoma of breast |
| 8542/3 | Paget disease, extramammary |
| 8543/3 | Paget disease and intraductal carcinoma of breast |
| 8550/0 | Acinar cell adenoma |
| 8550/1 | Acinar cell tumour |
| 8550/3 | Acinar cell carcinoma |
| 8551/3 | Acinar cell cystadenocarcinoma |
| 8552/3 | Mixed acinar-ductal carcinoma |
| 8560/0 | Mixed squamous cell and glandular papilloma |
| 8560/3 | Adenosquamous carcinoma |
| 8561/0 | Adenolymphoma |
| 8562/3 | Epithelial-myoepithelial carcinoma |
| 8563/0 | Lymphadenoma |
| 8570/3 | Adenocarcinoma with squamous metaplasia |
| 8571/3 | Adenocarcinoma with cartilaginous and osseous metaplasia |
| 8572/3 | Adenocarcinoma with spindle cell metaplasia |
| 8573/3 | Adenocarcinoma with apocrine metaplasia |
| 8574/3 | Adenocarcinoma with neuroendocrine differentiation |
| 8575/3 | Metaplastic carcinoma, NOS |
| 8576/3 | Hepatoid adenocarcinoma |
| 8580/0 | Microscopic thymoma |
| 8580/1 | Micronodular thymoma with lymphoid stroma |
| 8580/3 | Thymoma, NOS |
| 8581/3 | Thymoma, type A |
| 8582/3 | Thymoma, type AB |
| 8583/3 | Thymoma, type B1 |
| 8584/3 | Thymoma, type B2 |
| 8585/3 | Thymoma, type B3 |
| 8586/3 | Thymic carcinoma, NOS |
| 8587/0 | Ectopic hamartomatous thymoma |
| 8588/3 | Spindle epithelial tumour with thymus-like element |
| 8589/3 | Intrathyroid thymic carcinoma |
| 8590/0 | Sex cord-stromal tumour, benign |
| 8590/1 | Sex cord-gonadal stromal tumour, NOS |
| 8591/1 | Sex cord-gonadal stromal tumour, incompletely differentiated |
| 8592/1 | Sex cord-gonadal stromal tumour, mixed forms |
| 8593/1 | Stromal tumour with minor sex cord elements |
| 8594/1 | Mixed germ cell-sex cord-stromal tumour, NOS |
| 8600/0 | Thecoma, NOS |
| 8600/3 | Thecoma, malignant |
| 8601/0 | Thecoma, luteinized |
| 8602/0 | Sclerosing stromal tumour |
| 8610/0 | Luteoma, NOS |
| 8620/1 | Adult granulosa cell tumour of testis |
| 8620/3 | Adult granulosa cell tumour of ovary |
| 8621/1 | Granulosa cell-theca cell tumour |
| 8622/0 | Granulosa cell tumour of the testis, juvenile |
| 8622/1 | Granulosa cell tumour, juvenile |
| 8623/1 | Sex cord tumour with annular tubules |
| 8630/0 | Androblastoma, benign |
| 8630/1 | Androblastoma, NOS |
| 8630/3 | Androblastoma, malignant |
| 8631/0 | Sertoli-Leydig cell tumour, well differentiated |
| 8631/1 | Sertoli-Leydig cell tumour of intermediate differentiation |
| 8631/3 | Sertoli-Leydig cell tumour, poorly differentiated |
| 8632/1 | Gynandroblastoma |
| 8633/1 | Sertoli-Leydig cell tumour, retiform |
| 8634/1 | Sertoli-Leydig cell tumour, intermediate differentiation, with heterologous elements |
| 8634/3 | Sertoli-Leydig cell tumour, poorly differentiated, with heterologous elements |
| 8640/1 | Sertoli cell tumour, NOS |
| 8640/3 | Sertoli cell carcinoma |
| 8641/0 | Sertoli cell tumour with lipid storage |
| 8642/1 | Large cell calcifying Sertoli cell tumour |
| 8643/1 | Intratubular large cell hyalinizing Sertoli cell neoplasia |
| 8650/0 | Leydig cell tumour of the ovary, NOS |
| 8650/1 | Leydig cell tumour of the testis, NOS |
| 8650/3 | Leydig cell tumour, malignant |
| 8660/0 | Hilus cell tumour |
| 8670/0 | Lipid cell tumour of ovary |
| 8670/3 | Steroid cell tumour, malignant |
| 8671/0 | Adrenal rest tumour |
| 8680/3 | Paraganglioma, NOS |
| 8681/3 | Sympathetic paraganglioma |
| 8682/3 | Parasympathetic paraganglioma |
| 8683/0 | Gangliocytic paraganglioma |
| 8690/3 | Middle ear paraganglioma |
| 8691/3 | Aortic body tumour |
| 8692/3 | Carotid body paraganglioma |
| 8693/3 | Extra-adrenal paraganglioma |
| 8700/3 | Pheochromocytoma, NOS |
| 8710/3 | Glomangiosarcoma |
| 8711/0 | Glomus tumour, NOS |
| 8711/1 | Glomangiomatosis |
| 8711/3 | Glomus tumour, malignant |
| 8712/0 | Glomangioma |
| 8713/0 | Glomangiomyoma |
| 8714/0 | Perivascular epithelioid tumour, benign |
| 8714/3 | Perivascular epithelioid tumour, malignant |
| 8720/0 | Pigmented naevus, NOS |
| 8720/2 | Melanoma in situ |
| 8720/3 | Malignant melanoma, NOS |
| 8721/3 | Nodular melanoma |
| 8722/0 | Balloon cell naevus |
| 8722/3 | Balloon cell melanoma |
| 8723/0 | Halo naevus |
| 8723/3 | Malignant melanoma, regressing |
| 8725/0 | Neuronevus |
| 8726/0 | Magnocellular naevus |
| 8727/0 | Dysplastic naevus |
| 8728/0 | Meningeal melanocytosis |
| 8728/1 | Meningeal melanocytoma |
| 8728/3 | Meningeal melanomatosis |
| 8730/0 | Nonpigmented naevus |
| 8730/3 | Amelanotic melanoma |
| 8740/0 | Junctional naevus, NOS |
| 8740/3 | Malignant melanoma in junctional naevus |
| 8741/2 | Precancerous melanosis, NOS |
| 8741/3 | Malignant melanoma in precancerous melanosis |
| 8742/0 | Lentiginous melanocytic naevus |
| 8742/2 | Lentigo maligna |
| 8742/3 | Lentigo maligna melanoma |
| 8743/3 | Low cumulative sun damage melanoma |
| 8744/0 | Acral naevus |
| 8744/3 | Acral melanoma |
| 8745/3 | Desmoplastic melanoma, NOS |
| 8746/3 | Mucosal lentiginous melanoma |
| 8750/0 | Dermal naevus |
| 8760/0 | Compound naevus |
| 8761/0 | Congenital melanocytic naevus, NOS |
| 8761/1 | Giant pigmented naevus, NOS |
| 8761/3 | Malignant melanoma arising in giant congenital naevus |
| 8762/1 | Proliferative dermal lesion in congenital naevus |
| 8770/0 | Epithelioid and spindle cell naevus |
| 8770/3 | Malignant Spitz tumour |
| 8771/0 | Epithelioid cell naevus |
| 8771/3 | Epithelioid cell melanoma |
| 8772/0 | Spindle cell naevus, NOS |
| 8772/3 | Spindle cell melanoma, NOS |
| 8773/3 | Spindle cell melanoma, type A |
| 8774/3 | Spindle cell melanoma, type B |
| 8780/0 | Blue nevus, NOS |
| 8780/1 | Pigmented epithelioid melanocytoma |
| 8780/3 | Blue naevus, malignant |
| 8790/0 | Cellular blue naevus |
| 8800/0 | Soft tissue tumour, benign |
| 8800/3 | Sarcoma, NOS |
| 8800/9 | Sarcomatosis, NOS |
| 8801/3 | Spindle cell sarcoma |
| 8802/1 | Pleomorphic hyalinizing angiectatic tumour |
| 8802/3 | Giant cell sarcoma |
| 8803/3 | Small cell sarcoma |
| 8804/3 | Epithelioid sarcoma |
| 8805/3 | Undifferentiated sarcoma |
| 8806/3 | Desmoplastic small round cell tumour |
| 8810/0 | Fibroma, NOS |
| 8810/1 | Cellular fibroma |
| 8810/3 | Fibrosarcoma, NOS |
| 8811/0 | Fibromyxoma |
| 8811/1 | Myxoinflammatory fibroblastic sarcoma |
| 8811/3 | Myxofibrosarcoma |
| 8812/0 | Periosteal fibroma |
| 8812/3 | Periosteal fibrosarcoma |
| 8813/0 | Fibroma of tendon sheath |
| 8813/1 | Palmar/plantar type fibromatosis |
| 8813/3 | Fascial fibrosarcoma |
| 8814/3 | Infantile fibrosarcoma |
| 8815/0 | Solitary fibrous tumour/Haemangiopericytoma, grade 1 |
| 8815/1 | Solitary fibrous tumour, NOS |
| 8815/3 | Solitary fibrous tumour, malignant |
| 8816/0 | Calcifying aponeurotic fibroma |
| 8817/0 | Calcifying fibrous tumour |
| 8818/0 | Fibrous dysplasia |
| 8820/0 | Elastofibroma |
| 8821/1 | Aggressive fibromatosis |
| 8822/1 | Abdominal fibromatosis |
| 8823/0 | Sclerotic fibroma |
| 8823/1 | Desmoplastic fibroma |
| 8824/0 | Myofibroma |
| 8824/1 | Myofibromatosis |
| 8825/0 | Myofibroblastoma |
| 8825/1 | Myofibroblastic tumour, NOS |
| 8825/3 | Myofibroblastic sarcoma |
| 8826/0 | Angiomyofibroblastoma |
| 8827/1 | Myofibroblastic tumour, peribronchial |
| 8828/0 | Nodular fasciitis |
| 8830/0 | Benign fibrous histiocytoma |
| 8830/1 | Atypical fibrous histiocytoma |
| 8830/3 | Malignant fibrous histiocytoma |
| 8831/0 | Histiocytoma, NOS |
| 8832/0 | Dermatofibroma, NOS |
| 8832/1 | Dermatofibrosarcoma protuberans, NOS |
| 8832/3 | Dermatofibrosarcoma protuberans, fibrosarcomatous |
| 8833/1 | Pigmented dermatofibrosarcoma protuberans |
| 8834/1 | Giant cell fibroblastoma |
| 8835/1 | Plexiform fibrohistiocytic tumour |
| 8836/1 | Angiomatoid fibrous histiocytoma |
| 8840/0 | Myxoma, NOS |
| 8840/3 | Myxosarcoma |
| 8841/0 | Angiomyxoma |
| 8842/0 | Ossifying fibromyxoid tumour |
| 8842/3 | Ossifying fibromyxoid tumour, malignant |
| 8850/0 | Lipoma, NOS |
| 8850/1 | Atypical lipomatous tumour |
| 8850/3 | Liposarcoma, NOS |
| 8851/0 | Fibrolipoma |
| 8851/1 | Lipofibromatosis |
| 8851/3 | Liposarcoma, well differentiated |
| 8852/0 | Fibromyxolipoma |
| 8852/3 | Myxoid liposarcoma |
| 8854/0 | Pleomorphic lipoma |
| 8854/3 | Pleomorphic liposarcoma |
| 8855/3 | Mixed liposarcoma |
| 8856/0 | Intramuscular lipoma |
| 8857/0 | Spindle cell lipoma |
| 8857/3 | Fibroblastic liposarcoma |
| 8858/3 | Dedifferentiated liposarcoma |
| 8860/0 | Angiomyolipoma |
| 8860/1 | Angiomyolipoma, Epithelioid |
| 8861/0 | Angiolipoma, NOS |
| 8862/0 | Chondroid lipoma |
| 8870/0 | Myelolipoma |
| 8880/0 | Hibernoma |
| 8881/0 | Lipoblastomatosis |
| 8890/0 | Leiomyoma, NOS |
| 8890/1 | Leiomyomatosis, NOS |
| 8890/3 | Leiomyosarcoma, NOS |
| 8891/0 | Epithelioid leiomyoma |
| 8891/3 | Epithelioid leiomyosarcoma |
| 8892/0 | Cellular leiomyoma |
| 8893/0 | Bizarre leiomyoma |
| 8894/0 | Angiomyoma |
| 8894/3 | Angiomyosarcoma |
| 8895/0 | Myoma |
| 8895/3 | Myosarcoma |
| 8896/0 | Myxoid leiomyoma |
| 8896/3 | Myxoid leiomyosarcoma |
| 8897/1 | Smooth muscle tumour of uncertain malignant potential |
| 8898/1 | Metastasizing leiomyoma |
| 8900/0 | Rhabdomyoma, NOS |
| 8900/3 | Rhabdomyosarcoma, NOS |
| 8901/3 | Pleomorphic rhabdomyosarcoma, adult type |
| 8902/3 | Mixed type rhabdomyosarcoma |
| 8903/0 | Fetal rhabdomyoma |
| 8904/0 | Adult cellular rhabdomyoma |
| 8905/0 | Genital rhabdomyoma |
| 8910/3 | Embryonal rhabdomyosarcoma, NOS |
| 8912/3 | Spindle cell rhabdomyosarcoma |
| 8920/3 | Alveolar rhabdomyosarcoma |
| 8921/3 | Ectomesenchymoma |
| 8930/0 | Endometrial stromal nodule |
| 8930/3 | Endometrial stromal sarcoma, NOS |
| 8931/3 | Endometrial stromal sarcoma, low grade |
| 8932/0 | Adenomyoma |
| 8933/3 | Adenosarcoma |
| 8934/3 | Carcinofibroma |
| 8935/0 | Stromal tumour, benign |
| 8935/1 | Stromal tumour, NOS |
| 8935/3 | Stromal sarcoma, NOS |
| 8936/3 | Gastrointestinal stromal tumour |
| 8940/0 | Pleomorphic adenoma |
| 8940/3 | Mixed tumour, malignant, NOS |
| 8941/3 | Carcinoma ex pleomorphic adenoma |
| 8950/3 | Mullerian mixed tumour |
| 8951/3 | Mesodermal mixed tumour |
| 8959/0 | Benign cystic nephroma |
| 8959/1 | Cystic partially differentiated nephroblastoma |
| 8959/3 | Malignant cystic nephroma |
| 8960/1 | Mesoblastic nephroma |
| 8960/3 | Nephroblastoma, NOS |
| 8963/3 | Rhabdoid tumour, NOS |
| 8964/3 | Clear cell sarcoma of kidney |
| 8966/0 | Renomedullary interstitial cell tumour |
| 8967/0 | Ossifying renal tumour |
| 8970/3 | Hepatoblastoma |
| 8971/3 | Pancreatoblastoma |
| 8972/3 | Pulmonary blastoma |
| 8973/3 | Pleuropulmonary blastoma |
| 8974/1 | Sialoblastoma |
| 8975/1 | Calcifying nested stromal-epithelial tumour |
| 8980/3 | Carcinosarcoma, NOS |
| 8981/3 | Carcinosarcoma, embryonal |
| 8982/0 | Myoepithelioma |
| 8982/3 | Myoepithelial carcinoma |
| 8983/0 | Adenomyoepithelioma, NOS |
| 8983/3 | Adenomyoepithelioma with carcinoma |
| 8990/0 | Mesenchymoma, benign |
| 8990/1 | Mesenchymoma, NOS |
| 8990/3 | Mesenchymoma, malignant |
| 8991/3 | Embryonal sarcoma |
| 8992/0 | Pulmonary hamartoma |
| 9000/0 | Brenner tumour, NOS |
| 9000/1 | Brenner tumour, borderline malignancy |
| 9000/3 | Brenner tumour, malignant |
| 9010/0 | Fibroadenoma, NOS |
| 9011/0 | Intracanalicular fibroadenoma |
| 9012/0 | Pericanalicular fibroadenoma |
| 9013/0 | Adenofibroma, NOS |
| 9014/0 | Serous adenofibroma, NOS |
| 9014/1 | Serous adenofibroma of borderline malignancy |
| 9014/3 | Serous adenocarcinofibroma |
| 9015/0 | Mucinous adenofibroma, NOS |
| 9015/1 | Mucinous adenofibroma of borderline malignancy |
| 9015/3 | Mucinous adenocarcinofibroma |
| 9016/0 | Giant fibroadenoma |
| 9020/0 | Phyllodes tumour, benign |
| 9020/1 | Phyllodes tumour, borderline |
| 9020/3 | Phyllodes tumour, malignant |
| 9030/0 | Juvenile fibroadenoma |
| 9040/0 | Synovioma, benign |
| 9040/3 | Synovial sarcoma, NOS |
| 9041/3 | Synovial sarcoma, spindle cell |
| 9042/3 | Synovial sarcoma, epithelioid cell |
| 9043/3 | Synovial sarcoma, biphasic |
| 9044/3 | Clear cell sarcoma, NOS |
| 9045/3 | Biphenotypic sinonasal sarcoma |
| 9050/0 | Mesothelioma, benign |
| 9050/3 | Mesothelioma, malignant |
| 9051/0 | Fibrous mesothelioma, benign |
| 9051/3 | Fibrous mesothelioma, malignant |
| 9052/0 | Epithelioid mesothelioma, benign |
| 9052/1 | Well differentiated papillary mesothelioma of the pleura |
| 9052/3 | Epithelioid mesothelioma, malignant |
| 9053/3 | Mesothelioma, biphasic, malignant |
| 9054/0 | Adenomatoid tumour, NOS |
| 9055/0 | Peritoneal inclusion cysts |
| 9060/3 | Dysgerminoma |
| 9061/3 | Seminoma, NOS |
| 9062/3 | Seminoma, anaplastic |
| 9063/3 | Spermatocytic seminoma |
| 9064/2 | Intratubular malignant germ cells |
| 9064/3 | Germinoma |
| 9065/3 | Germ cell tumour, nonseminomatous |
| 9070/3 | Embryonal carcinoma, NOS |
| 9071/3 | Yolk sac tumour |
| 9072/3 | Polyembryoma |
| 9073/1 | Gonadoblastoma |
| 9080/0 | Teratoma, benign |
| 9080/1 | Teratoma, NOS |
| 9080/3 | Teratoma, malignant, NOS |
| 9081/3 | Teratocarcinoma |
| 9082/3 | Malignant teratoma, undifferentiated |
| 9083/3 | Malignant teratoma, intermediate |
| 9084/0 | Dermoid cyst, NOS |
| 9084/3 | Teratoma with malignant transformation |
| 9085/3 | Mixed germ cell tumour |
| 9086/3 | Germ cell tumour with associated haematological malignancy |
| 9090/0 | Struma ovarii, NOS |
| 9090/3 | Struma ovarii, malignant |
| 9091/1 | Strumal carcinoid |
| 9100/0 | Hydatidiform mole, NOS |
| 9100/1 | Invasive hydatidiform mole |
| 9100/3 | Choriocarcinoma, NOS |
| 9101/3 | Choriocarcinoma combined with other germ cell elements |
| 9102/3 | Malignant teratoma, trophoblastic |
| 9103/0 | Partial hydatidiform mole |
| 9104/1 | Placental site trophoblastic tumour |
| 9105/3 | Trophoblastic tumour, epithelioid |
| 9110/0 | Adenoma of rete ovarii |
| 9110/1 | Wolffian tumour |
| 9110/3 | Mesonephroma, malignant |
| 9120/0 | Haemangioma, NOS |
| 9120/3 | Hemangiosarcoma |
| 9121/0 | Cavernous haemangioma |
| 9122/0 | Venous haemangioma |
| 9123/0 | Racemose haemangioma |
| 9124/3 | Kupffer cell sarcoma |
| 9125/0 | Epithelioid haemangioma |
| 9126/0 | Atypical vascular lesion |
| 9130/0 | Haemangioendothelioma, benign |
| 9130/1 | Haemangioendothelioma, NOS |
| 9130/3 | Haemangioendothelioma, malignant |
| 9131/0 | Capillary haemangioma |
| 9132/0 | Intramuscular haemangioma |
| 9133/3 | Epithelioid haemangioendothelioma, NOS |
| 9135/1 | Papillary intralymphatic angioendothelioma |
| 9136/1 | Spindle cell haemangioendothelioma |
| 9137/0 | Myointimoma |
| 9137/3 | Intimal sarcoma |
| 9138/1 | Pseudomyogenic (epithelioid sarcoma-like) haemangioendothelioma |
| 9140/3 | Kaposi sarcoma |
| 9141/0 | Angiokeratoma |
| 9142/0 | Verrucous keratotic haemangioma |
| 9160/0 | Angiofibroma, NOS |
| 9161/0 | Acquired tufted haemangioma |
| 9161/1 | Haemangioblastoma |
| 9170/0 | Lymphangioma, NOS |
| 9170/3 | Lymphangiosarcoma |
| 9171/0 | Capillary lymphangioma |
| 9172/0 | Cavernous lymphangioma |
| 9173/0 | Cystic lymphangioma |
| 9174/0 | Lymphangiomyoma |
| 9174/1 | Lymphangiomyomatosis |
| 9175/0 | Haemolymphangioma |
| 9180/0 | Osteoma, NOS |
| 9180/3 | Osteosarcoma, NOS |
| 9181/3 | Chondroblastic osteosarcoma |
| 9182/3 | Fibroblastic osteosarcoma |
| 9183/3 | Telangiectatic osteosarcoma |
| 9184/3 | Osteosarcoma in Paget disease of bone |
| 9185/3 | Small cell osteosarcoma |
| 9186/3 | Central osteosarcoma |
| 9187/3 | Low grade central osteosarcoma |
| 9191/0 | Osteoid osteoma, NOS |
| 9192/3 | Parosteal osteosarcoma |
| 9193/3 | Periosteal osteosarcoma |
| 9194/3 | High grade surface osteosarcoma |
| 9195/3 | Intracortical osteosarcoma |
| 9200/0 | Osteoblastoma, NOS |
| 9200/1 | Aggressive osteoblastoma |
| 9210/0 | Osteochondroma |
| 9210/1 | Osteochondromatosis, NOS |
| 9211/0 | Osteochondromyxoma |
| 9212/0 | Bizarre parosteal osteochondromatous proliferation |
| 9213/0 | Subungual exostosis |
| 9220/0 | Chondroma, NOS |
| 9220/1 | Chondromatosis, NOS |
| 9220/3 | Chondrosarcoma, NOS |
| 9221/0 | Periosteal chondroma |
| 9221/3 | Periosteal chondrosarcoma |
| 9222/1 | Atypical cartilaginous tumour |
| 9230/1 | Chondroblastoma, NOS |
| 9230/3 | Chondroblastoma, malignant |
| 9231/3 | Myxoid chondrosarcoma |
| 9240/3 | Mesenchymal chondrosarcoma |
| 9241/0 | Chondromyxoid fibroma |
| 9242/3 | Clear cell chondrosarcoma |
| 9243/3 | Dedifferentiated chondrosarcoma |
| 9250/1 | Giant cell tumour of bone, NOS |
| 9250/3 | Giant cell tumour of bone, malignant |
| 9251/1 | Giant cell tumour of soft parts, NOS |
| 9251/3 | Malignant giant cell tumour of soft parts |
| 9252/0 | Tenosynovial giant cell tumour, NOS |
| 9252/1 | Tenosynovial giant cell tumour, diffuse |
| 9252/3 | Malignant tenosynovial giant cell tumour |
| 9260/0 | Aneurysmal bone cyst |
| 9261/3 | Adamantinoma of long bones |
| 9262/0 | Ossifying fibroma |
| 9270/0 | Odontogenic tumour, benign |
| 9270/1 | Odontogenic tumour, NOS |
| 9270/3 | Odontogenic tumour, malignant |
| 9271/0 | Ameloblastic fibrodentinoma |
| 9272/0 | Cementoma, NOS |
| 9273/0 | Cementoblastoma, benign |
| 9274/0 | Cemento-ossifying fibroma |
| 9275/0 | Gigantiform cementoma |
| 9280/0 | Odontoma, NOS |
| 9281/0 | Compound odontoma |
| 9282/0 | Complex odontoma |
| 9290/0 | Ameloblastic fibro-odontoma |
| 9290/3 | Ameloblastic odontosarcoma |
| 9300/0 | Adenomatoid odontogenic tumour |
| 9301/0 | Calcifying odontogenic cyst |
| 9302/0 | Dentinogenic ghost cell tumour |
| 9302/3 | Ghost cell odontogenic carcinoma |
| 9310/0 | Ameloblastoma, NOS |
| 9310/3 | Ameloblastoma, metastasizing |
| 9311/0 | Odontoameloblastoma |
| 9312/0 | Squamous odontogenic tumour |
| 9320/0 | Odontogenic myxoma |
| 9321/0 | Odontogenic fibroma, NOS |
| 9322/0 | Peripheral odontogenic fibroma |
| 9330/0 | Ameloblastic fibroma |
| 9330/3 | Ameloblastic fibrosarcoma |
| 9340/0 | Calcifying epithelial odontogenic tumour |
| 9341/3 | Clear cell odontogenic carcinoma |
| 9342/3 | Odontogenic carcinosarcoma |
| 9350/1 | Craniopharyngioma |
| 9351/1 | Craniopharyngioma, adamantinomatous |
| 9352/1 | Craniopharyngioma, papillary |
| 9360/1 | Pinealoma |
| 9361/1 | Pineocytoma |
| 9362/3 | Pineoblastoma |
| 9363/0 | Melanotic neuroectodermal tumour |
| 9364/3 | Ewing sarcoma |
| 9365/3 | Askin tumour |
| 9370/0 | Benign notochordal cell tumour |
| 9370/3 | Chordoma, NOS |
| 9371/3 | Chondroid chordoma |
| 9372/3 | Dedifferentiated chordoma |
| 9373/0 | Parachordoma |
| 9380/3 | Glioma, malignant |
| 9381/3 | Gliomatosis cerebri |
| 9382/3 | Oligoastrocytoma, NOS |
| 9383/1 | Subependymoma |
| 9384/1 | Subependymal giant cell astrocytoma |
| 9385/3 | Diffuse midline glioma, H3 K27M-mutant |
| 9390/0 | Choroid plexus papilloma, NOS |
| 9390/1 | Atypical choroid plexus papilloma |
| 9390/3 | Choroid plexus carcinoma |
| 9391/1 | Sellar ependymoma |
| 9391/3 | Ependymoma, NOS |
| 9392/3 | Ependymoma, anaplastic |
| 9393/3 | Papillary ependymoma |
| 9394/1 | Myxopapillary ependymoma |
| 9395/3 | Papillary tumour of the pineal region |
| 9396/3 | Ependymoma, RELA fusion-positive |
| 9400/3 | Astrocytoma, NOS |
| 9401/3 | Astrocytoma, anaplastic |
| 9410/3 | Protoplasmic astrocytoma |
| 9411/3 | Gemistocytic astrocytoma |
| 9412/1 | Desmoplastic infantile astrocytoma |
| 9413/0 | Dysembryoplastic neuroepithelial tumour |
| 9420/3 | Fibrillary astrocytoma |
| 9421/1 | Pilocytic astrocytoma |
| 9423/3 | Polar spongioblastoma |
| 9424/3 | Pleomorphic xanthoastrocytoma |
| 9425/3 | Pilomyxoid astrocytoma |
| 9430/3 | Astroblastoma |
| 9431/1 | Angiocentric glioma |
| 9432/1 | Pituicytoma |
| 9440/3 | Glioblastoma, NOS |
| 9441/3 | Giant cell glioblastoma |
| 9442/1 | Gliofibroma |
| 9442/3 | Gliosarcoma |
| 9444/1 | Chordoid glioma |
| 9445/3 | Glioblastoma, IDH mutant |
| 9450/3 | Oligodendroglioma, NOS |
| 9451/3 | Oligodendroglioma, anaplastic |
| 9460/3 | Oligodendroblastoma |
| 9470/3 | Medulloblastoma, NOS |
| 9471/3 | Desmoplastic nodular medulloblastoma |
| 9472/3 | Medullomyoblastoma |
| 9473/3 | CNS embryonal tumour, NOS |
| 9474/3 | Large cell medulloblastoma |
| 9475/3 | Medulloblastoma, WNT-activated, NOS |
| 9476/3 | Medulloblastoma, SHH-activated and TP53-mutant |
| 9477/3 | Medulloblastoma, non-WNT/non-SHH |
| 9478/3 | Embryonal tumours with multilayered rosettes with C19MC alteration |
| 9480/3 | Cerebellar sarcoma, NOS |
| 9490/0 | Ganglioneuroma |
| 9490/3 | Ganglioneuroblastoma |
| 9491/0 | Ganglioneuromatosis |
| 9492/0 | Gangliocytoma |
| 9493/0 | Dysplastic gangliocytoma of cerebellum (Lhermitte-Duclos) |
| 9500/3 | Neuroblastoma, NOS |
| 9501/0 | Medulloepithelioma, benign |
| 9501/3 | Medulloepithelioma, NOS |
| 9502/0 | Teratoid medulloepithelioma, benign |
| 9502/3 | Teratoid medulloepithelioma |
| 9503/3 | Neuroepithelioma, NOS |
| 9504/3 | Spongioneuroblastoma |
| 9505/1 | Ganglioglioma, NOS |
| 9505/3 | Ganglioglioma, anaplastic |
| 9506/1 | Central neurocytoma |
| 9507/0 | Pacinian tumour |
| 9508/3 | Atypical teratoid/rhabdoid tumour |
| 9509/1 | Papillary glioneuronal tumour |
| 9510/0 | Retinocytoma |
| 9510/3 | Retinoblastoma, NOS |
| 9511/3 | Retinoblastoma, differentiated |
| 9512/3 | Retinoblastoma, undifferentiated |
| 9513/3 | Retinoblastoma, diffuse |
| 9514/1 | Retinoblastoma, spontaneously regressed |
| 9520/3 | Olfactory neurogenic tumour |
| 9521/3 | Olfactory neurocytoma |
| 9522/3 | Olfactory neuroblastoma |
| 9523/3 | Olfactory neuroepithelioma |
| 9530/0 | Meningioma, NOS |
| 9530/3 | Meningioma, malignant |
| 9531/0 | Meningothelial meningioma |
| 9532/0 | Fibrous meningioma |
| 9533/0 | Psammomatous meningioma |
| 9534/0 | Angiomatous meningioma |
| 9535/0 | Haemangioblastic meningioma |
| 9537/0 | Transitional meningioma |
| 9538/1 | Clear cell meningioma |
| 9538/3 | Papillary meningioma |
| 9539/1 | Atypical meningioma |
| 9539/3 | Meningeal sarcomatosis |
| 9540/0 | Neurofibroma, NOS |
| 9540/3 | Malignant peripheral nerve sheath tumour |
| 9541/0 | Melanotic neurofibroma |
| 9542/3 | Malignant peripheral nerve sheath tumour, epithelioid |
| 9550/0 | Plexiform neurofibroma |
| 9560/0 | Schwannoma, NOS |
| 9560/1 | Melanotic schwannoma |
| 9560/3 | Neurilemoma, malignant |
| 9561/3 | Malignant peripheral nerve sheath tumour with rhabdomyoblastic differentiation |
| 9562/0 | Nerve sheath myxoma |
| 9563/0 | Nerve sheath tumour, NOS |
| 9570/0 | Neuroma, NOS |
| 9571/0 | Perineurioma, NOS |
| 9571/3 | Perineurioma, malignant |
| 9580/0 | Granular cell tumour, NOS |
| 9580/3 | Granular cell tumour, malignant |
| 9581/3 | Alveolar soft part sarcoma |
| 9582/0 | Granular cell tumour of the sellar region |
| 9590/3 | Malignant lymphoma, NOS |
| 9591/1 | Monoclonal B-cell lymphocytosis, NOS |
| 9591/3 | Malignant lymphoma, non-Hodgkin, NOS |
| 9596/3 | Composite Hodgkin and non-Hodgkin lymphoma |
| 9597/3 | Primary cutaneous follicle centre lymphoma |
| 9650/3 | Hodgkin lymphoma, NOS |
| 9651/3 | Hodgkin lymphoma, lymphocyte-rich |
| 9652/3 | Hodgkin lymphoma, mixed cellularity, NOS |
| 9653/3 | Hodgkin lymphoma, lymphocyte depletion, NOS |
| 9654/3 | Hodgkin lymphoma, lymphocyte depletion, diffuse fibrosis |
| 9655/3 | Hodgkin lymphoma, lymphocyte depletion, reticular |
| 9659/3 | Hodgkin lymphoma, nodular lymphocyte predominant |
| 9661/3 | Hodgkin granuloma |
| 9662/3 | Hodgkin sarcoma |
| 9663/3 | Hodgkin lymphoma, nodular sclerosis, NOS |
| 9664/3 | Hodgkin lymphoma, nodular sclerosis, cellular phase |
| 9665/3 | Hodgkin lymphoma, nodular sclerosis, grade 1 |
| 9667/3 | Hodgkin lymphoma, nodular sclerosis, grade 2 |
| 9671/3 | Lymphoplasmacytic lymphoma |
| 9673/1 | In situ mantle cell neoplasia |
| 9673/3 | Mantle cell lymphoma |
| 9675/3 | Malignant lymphoma, mixed small and large cell, diffuse |
| 9678/3 | Primary effusion lymphoma |
| 9679/3 | Mediastinal large B-cell lymphoma |
| 9680/1 | EBV positive mucocutaneous ulcer |
| 9680/3 | Diffuse large B-cell lymphoma, NOS |
| 9684/3 | Malignant lymphoma, large B-cell, diffuse, immunoblastic, NOS |
| 9687/3 | Burkitt lymphoma, NOS |
| 9688/3 | T-cell/histiocyte rich large B-cell lymphoma |
| 9689/3 | Splenic marginal zone B-cell lymphoma |
| 9690/3 | Follicular lymphoma, NOS |
| 9691/3 | Follicular lymphoma, grade 2 |
| 9695/1 | In situ follicular neoplasia |
| 9695/3 | Follicular lymphoma, grade 1 |
| 9698/3 | Follicular lymphoma, grade 3 |
| 9699/3 | Marginal zone B-cell lymphoma, NOS |
| 9700/3 | Mycosis fungoides |
| 9701/3 | Sezary syndrome |
| 9702/1 | Indolent T-cell lymphoproliferative disorder of gastrointestinal tract |
| 9702/3 | Mature T-cell lymphoma, NOS |
| 9705/3 | Angioimmunoblastic T-cell lymphoma |
| 9708/3 | Subcutaneous panniculitis-like T-cell lymphoma |
| 9709/1 | Primary cutaneous CD4 positive small/medium T-cell lymphoproliferative disorder |
| 9709/3 | Cutaneous T-cell lymphoma, NOS |
| 9712/3 | Intravascular large B-cell lymphoma |
| 9714/3 | Anaplastic large cell lymphoma, T cell and Null cell type |
| 9715/3 | Anaplastic large cell lymphoma, ALK negative |
| 9716/3 | Hepatosplenic T-cell lymphoma |
| 9717/3 | Intestinal T-cell lymphoma |
| 9718/1 | Primary cutaneous CD30+ T-cell lymphoproliferative disorder |
| 9718/3 | Primary cutaneous anaplastic large cell lymphoma |
| 9719/3 | NK/T-cell lymphoma, nasal and nasal-type |
| 9724/3 | Systemic EBV positive T-cell lymphoproliferative disease of childhood |
| 9725/1 | Hydroa vacciniforme-like lymphoproliferative disorder |
| 9726/3 | Primary cutaneous gamma/delta T-cell lymphoma |
| 9727/3 | Precursor cell lymphoblastic lymphoma, NOS |
| 9731/3 | Plasmacytoma, NOS |
| 9732/3 | Plasma cell myeloma |
| 9733/3 | Plasma cell leukaemia |
| 9734/3 | Plasmacytoma, extramedullary |
| 9735/3 | Plasmablastic lymphoma |
| 9737/3 | ALK positive large B-cell lymphoma |
| 9738/3 | Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease |
| 9740/1 | Mastocytoma, NOS |
| 9740/3 | Mast cell sarcoma |
| 9741/1 | Indolent systemic mastocytosis |
| 9741/3 | Malignant mastocytosis |
| 9742/3 | Mast cell leukaemia |
| 9749/3 | Erdheim-Chester disease |
| 9750/3 | Malignant histiocytosis |
| 9751/1 | Langerhans cell histiocytosis |
| 9751/3 | Langerhans cell histiocytosis, disseminated |
| 9755/3 | Histiocytic sarcoma |
| 9756/3 | Langerhans cell sarcoma |
| 9757/3 | Interdigitating dendritic cell sarcoma |
| 9758/3 | Follicular dendritic cell sarcoma |
| 9759/3 | Fibroblastic reticular cell tumour |
| 9760/3 | Immunoproliferative disease, NOS |
| 9761/1 | IgM monoclonal gammopathy of undetermined significance |
| 9761/3 | Waldenstrom macroglobulinemia |
| 9762/3 | Heavy chain disease, NOS |
| 9764/3 | Immunoproliferative small intestinal disease |
| 9765/1 | Monoclonal gammopathy of undetermined significance |
| 9766/1 | Angiocentric immunoproliferative lesion |
| 9766/3 | Lymphomatoid granulomatosis, grade 3 |
| 9767/1 | Angioimmunoblastic lymphadenopathy (AIL) |
| 9768/1 | T-gamma lymphoproliferative disease |
| 9769/1 | Immunoglobulin deposition disease |
| 9800/3 | Leukaemia, NOS |
| 9801/3 | Acute leukaemia, NOS |
| 9805/3 | Acute biphenotypic leukaemia |
| 9806/3 | Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 |
| 9807/3 | Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged |
| 9808/3 | Mixed phenotype acute leukaemia, B/myeloid, NOS |
| 9809/3 | Mixed phenotype acute leukaemia, T/myeloid, NOS |
| 9811/3 | B lymphoblastic leukaemia/lymphoma, NOS |
| 9812/3 | B lymphoblastic leukaemia/lymphoma with t(9;22)(q34;q11.2); BCR-ABL1 |
| 9813/3 | B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged |
| 9814/3 | B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) |
| 9815/3 | B lymphoblastic leukaemia/lymphoma with hyperdiploidy |
| 9816/3 | B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) |
| 9817/3 | B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH |
| 9818/3 | B lymphoblastic leukaemia/lymphoma with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) |
| 9819/3 | B lymphoblastic leukemia/lymphoma, BCR-ABL1-like |
| 9820/3 | Lymphoid leukaemia, NOS |
| 9823/1 | Monoclonal B-cell lymphocytosis, CLL type |
| 9823/3 | B-cell chronic lymphocytic leukaemia/small lymphocytic lymphoma |
| 9827/3 | Adult T-cell leukaemia/lymphoma (HTLV-1 positive) |
| 9831/3 | T-cell large granular lymphocytic leukaemia |
| 9832/3 | Prolymphocytic leukaemia, NOS |
| 9833/3 | Prolymphocytic leukaemia, B-cell type |
| 9834/3 | Prolymphocytic leukaemia, T-cell type |
| 9835/3 | Precursor cell lymphoblastic leukaemia, NOS |
| 9837/3 | Precursor T-cell lymphoblastic leukaemia |
| 9840/3 | Acute erythroid leukemia |
| 9860/3 | Myeloid leukaemia, NOS |
| 9861/3 | Acute myeloid leukaemia, NOS |
| 9863/3 | Chronic myeloid leukaemia, NOS |
| 9865/3 | Acute myeloid leukaemia with t(6;9)(p23;q34); DEK-NUP214 |
| 9866/3 | Acute promyelocytic leukaemia, t(15;17)(q22;q11-12) |
| 9867/3 | Acute myelomonocytic leukaemia |
| 9869/3 | Acute myeloid leukaemia with inv(3)(q21;q26.2) or t(3.3)(q21;q26.2); RPN1-EVI1 |
| 9870/3 | Acute basophilic leukaemia |
| 9871/3 | Acute myeloid leukaemia with abnormal marrow eosinophils |
| 9872/3 | Acute myeloid leukaemia, minimal differentiation |
| 9873/3 | Acute myeloid leukaemia without maturation |
| 9874/3 | Acute myeloid leukaemia with maturation |
| 9875/3 | Chronic myelogenous leukaemia, BCR/ABL positive |
| 9876/3 | Atypical chronic myeloid leukaemia, BCR/ABL negative |
| 9877/3 | Acute myeloid leukaemia with mutated NPM1 |
| 9878/3 | Acute myeloid leukemia with biallelic mutation of CEBPA |
| 9879/3 | Acute myeloid leukemia with mutated RUNX1 |
| 9891/3 | Acute monocytic leukaemia |
| 9895/3 | Acute myeloid leukaemia with myelodysplasia-related changes |
| 9896/3 | Acute myeloid leukaemia, t(8;21)(q22;q22) |
| 9897/3 | Acute myeloid leukaemia, 11q23 abnormalities |
| 9898/1 | Transient abnormal myelopoiesis |
| 9898/3 | Myeloid leukaemia associated with Down Syndrome |
| 9910/3 | Acute megakaryoblastic leukaemia |
| 9911/3 | Acute myeloid leukaemia (megakaryoblastic) with t(1;22)(p13;q13); RBM15-MKL1 |
| 9912/3 | Acute myeloid leukemia with BCR-ABL1 |
| 9920/3 | Therapy related myeloid neoplasm |
| 9930/3 | Myeloid sarcoma |
| 9931/3 | Acute panmyelosis with myelofibrosis |
| 9940/3 | Hairy cell leukaemia |
| 9945/3 | Chronic myelomonocytic leukaemia, NOS |
| 9946/3 | Juvenile myelomonocytic leukaemia |
| 9948/3 | Aggressive NK-cell leukaemia |
| 9950/3 | Polycythaemia vera |
| 9960/3 | Myeloproliferative neoplasm, NOS |
| 9961/3 | Primary myelofibrosis |
| 9962/3 | Essential thrombocythemia |
| 9963/3 | Chronic neutrophilic leukaemia |
| 9964/3 | Chronic eosinophilic leukaemia |
| 9965/3 | Myeloid and lymphoid neoplasms with PDGFRA rearrangement |
| 9966/3 | Myeloid neoplasms with PDGFRB rearrangement |
| 9967/3 | Myeloid and lymphoid neoplasms with FGFR1 abnormalities |
| 9968/3 | Myeloid or lymphoid neoplasm with PCM1-JAK2 |
| 9970/1 | Lymphoproliferative disorder, NOS |
| 9971/1 | Post transplant lymphoproliferative disorder, NOS |
| 9975/3 | Myeloproliferative neoplasm, unclassifiable |
| 9982/3 | Myelodysplastic syndrome with ring sideroblasts and single lineage dysplasia |
| 9983/3 | Myelodysplastic syndrome with excess blasts |
| 9984/3 | Refractory anaemia with excess blasts in transformation |
| 9985/3 | Myelodysplastic syndrome with multilineage dysplasia |
| 9986/3 | Myelodysplastic syndrome with isolated del (5q) |
| 9987/3 | Therapy-related myelodysplastic syndrome, NOS |
| 9989/3 | Myelodysplastic syndrome, NOS |
| 9993/3 | Myelodysplastic syndrome with ring sideroblasts and multilineage dysplasia |
| 8408/3 | Digital papillary adenocarcinoma |
| 8442/1 | Serous borderline tumour, NOS |
| 9980/3 | Myelodysplastic syndrome with single lineage dysplasia |
Expansion based on code system fragment http://terminology.hl7.org/CodeSystem/icd-o-3 International Classification of Diseases for Oncology, version 3. version2000
Expansion from tx.fhir.org based on codesystem International Classification of Diseases for Oncology, version 3. version2000
This value set contains at least 3 concepts
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
IG © 2024+ MyHealth@Eu. Package myhealth.eu.fhir.hdr#0.0.1 based on FHIR 4.0.1. Generated 2025-06-06
